Bioniz Therapeutics, Inc.
Records under this name other than the patents Bioniz Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 5 of 5 · Back to Bioniz Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,400,134 | Modulating Gamma-C-Cytokine Activity Lapsed on the fee record Ended Aug 2, 2026 · High confidence | Lapsed on the fee record | Ended Aug 2, 2026 | High confidence |
| US 10,030,058 | Modulating Gamma-C-Cytokine Activity Lapsed on the fee record Ended Jul 24, 2026 · High confidence | Lapsed on the fee record | Ended Jul 24, 2026 | High confidence |
| US 10,030,059 | Modulators of Gamma-C-Cytokine Activity Lapsed on the fee record Ended Jul 24, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 24, 2026 | Medium confidence |
| US 9,675,672 | Compositions and Methods for Modulating Gamma-C-Cytokine Activity Lapsed on the fee record Ended Jun 13, 2025 · Low confidence | Lapsed on the fee record | Ended Jun 13, 2025 | Low confidence |
| US 8,455,449 | Compositions and Methods for Modulating Gamma-C-Cytokine Activity Lapsed on the fee record Ended Jun 4, 2025 · Low confidence | Lapsed on the fee record | Ended Jun 4, 2025 | Low confidence |